PLAUR and non-small cell lung carcinoma: A dual-targeting DTAT-based BLT (DTATEGF) was synthesized to simultaneously target uPAR- and EGDR-expressing non-small-cell lung cancer (NSCLC) that has metastasized to the brain [187].